Skip to Content

Notice

Importer of Controlled Substances Application: Research Triangle Institute

This document has a comment period that ends in 17 days. (03/11/2019) Submit a formal comment

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 11, 2019. Such persons may also file a written request for a hearing on the application on or before March 11, 2019.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to Start Printed Page 2572exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

In accordance with 21 CFR 1301.34(a), this is notice that on May 2, 2016, Research Triangle Institute, 3040 East Cornwallis Road, Hermann Bldg., Room 106, Research Triangle Park, North Carolina 27709 has applied to be registered as an importer of the following basic classes of controlled substances.

Controlled substanceDrug codeSchedule
3-Fluoro-N-methylcathinone (3-FMC)1233I
Cathinone1235I
Methcathinone1237I
4-Fluoro-N-methylcathinone (4-FMC)1238I
Pentedrone (α-methylaminovalerophenone)1246I
Mephedrone (4-Methyl-N-methylcathinone)1248I
4-Methyl-N-ethylcathinone (4-MEC)1249I
Naphyrone1258I
N-Ethylamphetamine1475I
N,N-Dimethylamphetamine1480I
Fenethylline1503I
Aminorex1585I
4-Methylaminorex (cis isomer)1590I
Gamma Hydroxybutyric Acid2010I
Methaqualone2565I
Mecloqualone2572I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole)6250I
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole)7008I
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone7011I
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)7012I
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)7019I
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole3-carboxamide)7023I
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone7024I
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)1H-indazole-3-carboxamide7031I
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)7032I
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)7035I
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide7048I
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole)7081I
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole7104I
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)7118I
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole)7122I
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone7144I
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)7173I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole)7200I
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)7201I
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole)7203I
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate)7222I
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate)7225I
Alpha-ethyltryptamine7249I
Ibogaine7260I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol)7297I
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol)7298I
Lysergic acid diethylamide7315I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7)7348I
Marihuana7360I
Tetrahydrocannabinols7370I
Parahexyl7374I
Mescaline7381I
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 )7385I
3,4,5-Trimethoxyamphetamine7390I
4-Bromo-2,5-dimethoxyamphetamine7391I
4-Bromo-2,5-dimethoxyphenethylamine7392I
4-Methyl-2,5-dimethoxyamphetamine7395I
2,5-Dimethoxyamphetamine7396I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole)7398I
2,5-Dimethoxy-4-ethylamphetamine7399I
3,4-Methylenedioxyamphetamine7400I
5-Methoxy-3,4-methylenedioxyamphetamine7401I
N-Hydroxy-3,4-methylenedioxyamphetamine7402I
3,4-Methylenedioxy-N-ethylamphetamine7404I
3,4-Methylenedioxymethamphetamine7405I
4-Methoxyamphetamine7411I
Peyote7415I
5-Methoxy-N-N-dimethyltryptamine7431I
Start Printed Page 2573
Alpha-methyltryptamine7432I
Bufotenine7433I
Diethyltryptamine7434I
Dimethyltryptamine7435I
Psilocybin7437I
Psilocyn7438I
5-Methoxy-N,N-diisopropyltryptamine7439I
N-Ethyl-1-phenylcyclohexylamine7455I
1-(1-Phenylcyclohexyl)pyrrolidine7458I
1-[1-(2-Thienyl)cyclohexyl]piperidine7470I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine7473I
N-Ethyl-3-piperidyl benzilate7482I
N-Methyl-3-piperidyl benzilate7484I
N-Benzylpiperazine7493I
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP)7498I
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)7508I
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E )7509I
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)7517I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)7518I
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)7519I
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)7521I
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P)7524I
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 )7532I
MDPV (3,4-Methylenedioxypyrovalerone)7535I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe)7536I
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe)7537I
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe)7538I
Methylone (3,4-Methylenedioxy-N-methylcathinone)7540I
Butylone7541I
Pentylone7542I
alpha-pyrrolidinopentiophenone (α-PVP)7545I
alpha-pyrrolidinobutiophenone (α-PBP)7546I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)7694I
Acetyldihydrocodeine9051I
Benzylmorphine9052I
Codeine-N-oxide9053I
Cyprenorphine9054I
Desomorphine9055I
Etorphine (except HCl)9056I
Codeine methylbromide9070I
Dihydromorphine9145I
Difenoxin9168I
Heroin9200I
Hydromorphinol9301I
Methyldesorphine9302I
Methyldihydromorphine9304I
Morphine methylbromide9305I
Morphine methylsulfonate9306I
Morphine-N-oxide9307I
Myrophine9308I
Nicocodeine9309I
Nicomorphine9312I
Normorphine9313I
Pholcodine9314I
Thebacon9315I
Acetorphine9319I
Drotebanol9335I
Acetylmethadol9601I
Allylprodine9602I
Alphacetylmethadol except levo-alphacetylmethadol9603I
Alphameprodine9604I
Alphamethadol9605I
Benzethidine9606I
Betacetylmethadol9607I
Betameprodine9608I
Betamethadol9609I
Betaprodine9611I
Clonitazene9612I
Dextromoramide9613I
Diampromide9615I
Diethylthiambutene9616I
Dimenoxadol9617I
Dimepheptanol9618I
Start Printed Page 2574
Dimethylthiambutene9619I
Dioxaphetyl butyrate9621I
Dipipanone9622I
Ethylmethylthiambutene9623I
Etonitazene9624I
Etoxeridine9625I
Furethidine9626I
Hydroxypethidine9627I
Ketobemidone9628I
Levomoramide9629I
Levophenacylmorphan9631I
Morpheridine9632I
Noracymethadol9633I
Norlevorphanol9634I
Normethadone9635I
Norpipanone9636I
Phenadoxone9637I
Phenampromide9638I
Phenoperidine9641I
Piritramide9642I
Proheptazine9643I
Properidine9644I
Racemoramide9645I
Trimeperidine9646I
Phenomorphan9647I
Propiram9649I
1-Methyl-4-phenyl-4-propionoxypiperidine9661I
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine9663I
Tilidine9750I
Para-Fluorofentanyl9812I
3-Methylfentanyl9813I
Alpha-methylfentanyl9814I
Acetyl-alpha-methylfentanyl9815I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)9821I
Butyryl Fentanyl9822I
Beta-hydroxyfentanyl9830I
Beta-hydroxy-3-methylfentanyl9831I
Alpha-methylthiofentanyl9832I
3-Methylthiofentanyl9833I
Thiofentanyl9835I
Amphetamine1100II
Methamphetamine1105II
Lisdexamfetamine1205II
Phenmetrazine1631II
Methylphenidate1724II
Amobarbital2125II
Pentobarbital2270II
Secobarbital2315II
Glutethimide2550II
Nabilone7379II
1-Phenylcyclohexylamine7460II
Phencyclidine7471II
4-Anilino-N-phenethyl-4-piperidine (ANPP)8333II
Phenylacetone8501II
1-Piperidinocyclohexanecarbonitrile8603II
Alphaprodine9010II
Anileridine9020II
Coca Leaves9040II
Cocaine9041II
Codeine9050II
Etorphine HCl9059II
Dihydrocodeine9120II
Oxycodone9143II
Hydromorphone9150II
Diphenoxylate9170II
Ecgonine9180II
Ethylmorphine9190II
Hydrocodone9193II
Levomethorphan9210II
Levorphanol9220II
Isomethadone9226II
Meperidine9230II
Meperidine intermediate-A9232II
Start Printed Page 2575
Meperidine intermediate-B9233II
Meperidine intermediate-C9234II
Metazocine9240II
Methadone9250II
Methadone intermediate9254II
Metopon9260II
Dextropropoxyphene, bulk (non-dosage forms)9273II
Morphine9300II
Oripavine9330II
Thebaine9333II
Dihydroetorphine9334II
Opium, raw9600II
Opium extracts9610II
Opium fluid extract9620II
Opium tincture9630II
Opium, powdered9639II
Opium, granulated9640II
Levo-alphacetylmethadol9648II
Opium poppy9650II
Oxymorphone9652II
Noroxymorphone9668II
Poppy Straw Concentrate9670II
Phenazocine9715II
Piminodine9730II
Racemethorphan9732II
Racemorphan9733II
Alfentanil9737II
Remifentanil9739II
Sufentanil9740II
Carfentanil9743II
Tapentadol9780II
Bezitramide9800II
Fentanyl9801II
Moramide-intermediate9802II

The company plans to import small quantities of the listed controlled substances for the National Institute on Drug Abuse (NIDA) for research activities. The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes.

Start Signature

Dated: January 2, 2019.

John J. Martin,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2019-01523 Filed 2-6-19; 8:45 am]

BILLING CODE 4410-09-P